Umbilical cord mesenchymal stem cells transplantation in patients with systemic sclerosis: a 5-year follow-up study
ConclusionUMSCT may provide a safe and feasible treatment option for patients with moderate to severe SSc based on long-term follow-up data. The randomized controlled study will further confirm the clinical efficacy of UMSCT in SSc.Clinical Trial RegistrationClinicalTrials.gov Identifier: NCT00962923.Key Point•UMSCT is safe and effective for SSc patients.
Source: Clinical Rheumatology - Category: Rheumatology Source Type: research
More News: Cardiology | Clinical Trials | CT Scan | Disability | Heart | Hypertension | Interstitial Lung Disease | Laboratory Medicine | Lung Transplant | Rheumatology | Scleroderma | Skin | Stem Cell Therapy | Stem Cells | Study | Transplants | Ultrasound